Community/Retail

NVX-CoV2373 (Novavax) was found to provide 100% protection against moderate and severe disease and 90.4% efficacy overall in a phase 3 trial last year.

Sachin Nagrani, MD, the medical director of Heal, discusses Pfizer’s research assessing an Omicron-specific vaccine for adults aged 18 to 55 years.

Adversity has disproportionately hurt certain populations, including essential workers and women, the results of a new analysis show.

Prior studies indicate that CPAP treatment can significantly decrease sleepiness and depression while also protecting against high blood pressure.

One out of every 4 pharmacists in Georgia said emergency contraception was not available at the store and ended the call.

The claim is based on requested exemption from administering immunizations because of "needle phobia."

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown and a urologic surgeon, discusses hypoactive sexual desire disorder and the current treatments available for this medical condition.

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how building resilience in the medicine supply chain will help bolster preparedness for what may arise during the COVID-19 pandemic and beyond.

This Valentine’s Day, pharmacists can remind patients that they may not need to feel guilty when they indulge in a small piece of chocolate.

Tresiba is indicated to improve glycemic control in patients with diabetes.

Bebtelovimab gets Emergency Use Authorization to treat mild-to-moderate COVID-19 in adults and pediatric patients who are at high risk for progression to severe COVID-19.

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses contributing factors leading to health care professionals experience of an erosion of trust in the medicine supply chain.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, discusses the future of ketamine and psychedelic medicines in the treatment of mental health and brain disorders.

New analysis shows the substitution would cut costs by $600 million in the United States annually.

American Heart Month is another example of the essential and valuable position that pharmacists hold in improving health care outcomes and optimizing patient-centered care.

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how drug shortages are related to medicine quality issues.

Study shows that 98% of cases of multi-system inflammatory syndrome in children (MIS-C) were unvaccinated, suggesting that vaccination reduces the chance of a child who had COVID-19 later developing MIS-C.

Joint Complex supports joint function and lubrication, as well as tissue hydration.

Edoxaban (Savaysa) can reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, addresses how pharmacists can respond to questions patients may ask them about ketamine and other psychedelic treatments.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, explains how ketamine infusions work when administered in patients’ homes and what safety precautions would be taken by providers in this setting.

New composite pharmacy adherence measure is a major step in developing standard pharmacy performance measures focused on improving patient care.

Increasing physical activities and reducing caloric intake isn’t always enough to conquer obesity.

Many faculty members are adept at training and teaching pharmacists and pharmacy technicians how to perform physical exams and tests.

Taking appropriate doses of vitamins and minerals may aid in lowering the risk of cardiovascular disease.

Lack of immediate results, cultural barriers, and high costs lead many to gamble with their cardiovascular health, study results show.

Tralokinumab-ldrm is an interleukin-13 antagonist recently approved for the treatment of moderate-to-severe atopic dermatitis.

Sagely Naturals Pain Relief Cream combines CBD with powerful botanicals, peppermint, and menthol.

Pharmacists are taking advantage of new opportunities, but there remain many other opportunities yet to be seized.

The calculation instrument displayed good discrimination, with a C-index of 0.72, as well as good calibration, investigators say.